United States · Biotechnology startup
United States · Avila Therapeutics
Avila Therapeutics is a biotechnology company focused on the development of covalent drugs to treat cancer and other autoimmune diseases.
Funding reportedLast round: Undisclosed round
What company datasets say Avila Therapeutics raised
Funding, as reported
Reported in all$59Min dollars
Rounds5
Last roundUndisclosed round
Last round dateDec 2020
Investors listed7
Founders and team
From the SEC filings it signed: 3 on the team.
- Katrine BosleyExecutive Officer, Directori
- Michael F. BighamExecutive Officer, Directori
- Roy R. LobbExecutive Officer, Directori
On the board, as filediAmir R. NashatBruce F. BoothDaniel R. LynchHenry R. SkinnerRaj R. ParekhVicki R. Sato
How it ended, so far
Exit
ExitBuyerPriceWhen
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Avila Therapeutics in front of investors. Or tell us what we have wrong.